Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine Hoffmann

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biological Chemistry|November 26, 2005
Cytosolic persistence of mouse brain CYP1A1 in chronic heme deficiencyRalf P Meyer, Raija L P Lindberg, Francine Hoffmann, et al.
European Journal of Immunology|February 12, 2010
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patientsRaija L P Lindberg, Francine Hoffmann, Matthias Mehling, et al.
Journal of Neuroimmunology|January 8, 2008
Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patientsRaija L P Lindberg, Lutz Achtnichts, Francine Hoffmann, et al.
Clinical Immunology (Orlando, Fla.)|June 5, 2012
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effectsClaudia Sievers, Maria Meira, Francine Hoffmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2014
MiR-126: a novel route for natalizumab action?Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Immunology Research|June 6, 2014
Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Neuroimmunology|June 30, 2004
Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MSRaija L P Lindberg, Corline J A De Groot, Ulrich Certa, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 4, 2020
PARP-1 deregulation in multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Brain : a Journal of Neurology|November 11, 2003
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPsFrancesca Gilli, Antonio Bertolotto, Arianna Sala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 19, 2016
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biological Chemistry|November 26, 2005
Cytosolic persistence of mouse brain CYP1A1 in chronic heme deficiencyRalf P Meyer, Raija L P Lindberg, Francine Hoffmann, et al.
European Journal of Immunology|February 12, 2010
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patientsRaija L P Lindberg, Francine Hoffmann, Matthias Mehling, et al.
Journal of Neuroimmunology|January 8, 2008
Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patientsRaija L P Lindberg, Lutz Achtnichts, Francine Hoffmann, et al.
Clinical Immunology (Orlando, Fla.)|June 5, 2012
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effectsClaudia Sievers, Maria Meira, Francine Hoffmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2014
MiR-126: a novel route for natalizumab action?Maria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Immunology Research|June 6, 2014
Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Journal of Neuroimmunology|June 30, 2004
Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MSRaija L P Lindberg, Corline J A De Groot, Ulrich Certa, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 4, 2020
PARP-1 deregulation in multiple sclerosisMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Brain : a Journal of Neurology|November 11, 2003
Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPsFrancesca Gilli, Antonio Bertolotto, Arianna Sala, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 19, 2016
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.
Pageof 2